Results 291 to 300 of about 7,587,845 (361)
Some of the next articles are maybe not open access.
Recombinant Protein Production in Yeasts
Molecular Biotechnology, 2005Recombinant DNA (rDNA) technologies (genetic, protein, and metabolic engineering) allow the production of a wide range of peptides, proteins, and biochemicals from naturally nonproducing cells. These technologies, now approx 25 yr old, have become one of the most important technologies developed in the twentieth century.
PORRO, DANILO +3 more
openaire +3 more sources
Recombinant Protein Production in Yeasts
2004Recombinant DNA (rDNA) technologies (genetic, protein, and metabolic engineering) allow the production of a wide range of peptides, proteins, and biochemicals from naturally nonproducing cells. This technology, now approx 25 yr old, is becoming one of the most important technologies developed in the 20th century.
Porro, D, Mattanovich, D
openaire +2 more sources
Recombinant protein expression: Challenges in production and folding related matters.
International Journal of Biological Macromolecules, 2023Protein folding is a biophysical process by which proteins reach a specific three-dimensional structure. The amino acid sequence of a polypeptide chain contains all the information needed to determine the final three-dimensional structure of a protein ...
A. Beygmoradi +3 more
semanticscholar +1 more source
Recombinant proteins for therapy
Trends in Pharmacological Sciences, 1996Recombinant therapeutic proteins have become increasingly important over the past ten years. Numerous products derived from 20 different proteins are already on the market. In this review Peter Buckel discusses the issues surrounding the use of recombinant proteins as therapeutic agents.
openaire +2 more sources
Recombinant Protein Production in Yeasts
2011Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging from bacterial hosts to mammalian cells have been established.
Mattanovich, D +5 more
openaire +3 more sources
Insights on the Formulation of Recombinant Proteins
2019Recombinant proteins are large and complex molecules, whose therapeutic activity highly depends on their structure. Formulation of biopharmaceuticals aims at stabilizing protein conformation, promoting its efficacy, and preventing safety concerns, such as immunogenicity. Currently, the rational design of formulations is possible due to the availability
Ribeiro, Rita +4 more
openaire +3 more sources
Application of Recombinant Proteins for Serodiagnosis of Visceral Leishmaniasis in Humans and Dogs
Iranian Biomedical Journal, 2016Visceral leishmaniasis (VL) is a zoonotic disease caused by leishmania species. Dogs are considered to be the main reservoir of VL. A number of methods and antigen-based assays are used for the diagnosis of leishmaniasis.
M. Farahmand, H. Nahrevanian
semanticscholar +1 more source
Making recombinant extracellular matrix proteins
Methods, 2008 International audienceA variety of approaches to understand extracellular matrix protein structure and function require production of recombinant proteins.
Florence Ruggiero, Manuel Koch
exaly +1 more source
Overview of the Characterization of Recombinant Proteins
Current Protocols in Protein Science, 1995AbstractThis overview provides guidelines for the characterization of recombinantly expressed proteins (e.g., verifying primary structure and appropriate post‐translational modifications), along with methodologies for characterizing the proteins according to size, X‐ray structure, absorbance, biological activity, and subunit structure.
Denslow, Nancy D. +2 more
openaire +3 more sources
Recombinant proteins for genetic disease
Clinical Genetics, 1999The era of molecular biology has led to the development of powerful tools capable of generating therapeutics for genetic disorders. Although there is much current emphasis placed on the development of ‘gene therapy’ for human disease, developments in the production and availability of recombinant proteins are likely to have a more substantial impact on
C S, Russell, L A, Clarke
openaire +2 more sources